PRESS RELEASE published on 08/06/2024 at 14:52, 2 years 1 month ago Inside Information / Other news releases Press release on the total number of shares and voting rights as per French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
PRESS RELEASE published on 08/06/2024 at 14:52, 2 years 1 month ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d'actions conformément à la réglementation financière en vigueur Autorité Des Marchés Financiers Code De Commerce Règlement Général Déclaration Réglementée Nombre Droits De Vote
BRIEF published on 07/16/2024 at 14:31, 2 years 1 month ago Arkema Discloses Recent Share Buyback Transactions Share Buyback Financial Transactions XPAR Market ARKEMA July 2024
BRIEF published on 07/16/2024 at 14:31, 2 years 1 month ago Arkema divulgue ses récentes opérations de rachat d'actions Rachat D'actions Transactions Financières Marché XPAR ARKEMA Juillet 2024
PRESS RELEASE published on 07/16/2024 at 14:26, 2 years 1 month ago Inside Information / Other news releases Arkema discloses share buyback transactions conducted from 08 July to 10 July 2024 in compliance with EU Regulation (EU) No 596/2014 Share Buyback Investor Relations Trading Regulation (EU) No 596/2014 ARKEMA
PRESS RELEASE published on 07/16/2024 at 14:26, 2 years 1 month ago Informations privilégiées / Autres communiqués Arkema déclare ses transactions sur actions propres du 08 au 10 juillet 2024, conformément à la réglementation. Consultez le site internet d'Arkema pour plus d'informations Actions Propres Rachat D'actions Transactions Réglementation ARKEMA
BRIEF published on 07/09/2024 at 11:41, 2 years 2 months ago Arkema Discloses Share Buyback Transactions Share Buyback Regulation 2024 Market Transactions ARKEMA
BRIEF published on 07/09/2024 at 11:41, 2 years 2 months ago Arkema annonce des opérations de rachat d'actions Rachat D'actions Regulation 2024 Opérations De Marché ARKEMA
PRESS RELEASE published on 07/09/2024 at 11:36, 2 years 2 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 01 to 05 July 2024, complying with EU regulation. Total daily volume: 35,000 shares, weighted average price: 83.9967. More info on Arkema's website Trading Own Shares EU Regulation ARKEMA Weighted Average Price
PRESS RELEASE published on 07/09/2024 at 11:36, 2 years 2 months ago Informations privilégiées / Autres communiqués Arkema déclare avoir effectué des achats d'actions propres conformément à la réglementation. Consultez le site web d'Arkema pour plus d'informations Réglementation Informations Achats D'actions Site Web ARKEMA
Published on 09/11/2026 at 04:00, 5 hours 4 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 39 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 44 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 4 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 48 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 1 hour 1 minute ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 33 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 58 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 2 hours 4 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 4 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 34 minutes ago Availability of the 2026 Interim Financial Report
